Yousef Badran

Physician-Scientist, @MGH_GI Gastroenterology, Immunology @Harvard Medical School, Genomics @Broadinstitute, EIR @Aditumbio

[Yousef Badran @YRBadran]

Great news for Versanis and Aditum bio!

[Daphne Zohar @daphnezohar]

$LLY to Acquire Versanis for “up to $1.925 B” don’t see the upfront piece disclosed https://t.co/Wmzyub1fwp

[Journal for ImmunoTherapy of Cancer @jitcancer]

New #JITC article: Concurrent immune checkpoint inhibition and selective immunosuppressive therapy in patients with immune-related enterocolitis https://t.co/z7w7E6Zo2u @YRBadran

[Yousef Badran @YRBadran]

Great working with you on this @DavidFaleckMD @MSKCancerCenter @MDAndersonNews !

[David Faleck @DavidFaleckMD]

Thrilled to share our study of concurrent biologic tx during ICI rechallenge after colitis.
👉 ⬇️ Recurrent severe colitis (20.8% vs 34.4%)
👉 No difference in safety outcomes or survival

https://t.co/AM5ZvbhCS6

@MSKCancerCenter @MPostow
@YRBadran @MGHMedicine
@MDAndersonNews

[Yousef Badran @YRBadran]

We report here the safety of using infliximab or vedolizumab concurrently with immune checkpoint therapy in patients with prior immune-checkpoint colitis ⭐️Recurrent severe colitis (20.8% (IFX or Vedo) vs 34.4% (control) https://t.co/wCppUg3dqo

[Yousef Badran @YRBadran]

@drraajmehta @MGH_RI @VertexPharma Big loss for MGH. You will be missed Raaj.

[Yousef Badran @YRBadran]

Incredible to see how different the dominant negative RELA phenotype is from our first report of RELA haploinsufficiency back in 2017
https://t.co/ybgsGq5Yui

beautiful work @SatoshiOkada3 @casanova_lab

[Casanova Lab @casanova_lab]

Beautiful paper expanding the fields of inborn errors of NF-kB and type I interferonopathies !

[Pradeep Natarajan @pnatarajanmd]

Somatic mosaicism is emerging as a new frontier in genomics.
@NIH has invested $140M to deeply characterize genomes across and within individuals.
Really excited to co-lead @broadinstitute's effort with @KArdlie @nialljlennon!
https://t.co/7krslPa2W1 #SMaHTConsortium

[Yousef Badran @YRBadran]

@mfalmeqdadi GPT4 clearly did a longer residency lol

[Yousef Badran @YRBadran]

I threw Bard a curveball!

[Yousef Badran @YRBadran]

@HebAltarawneh @mghmedres @Laith_AbuRaddad @HChemaitelly @AlJerdi @TArayssi @wcmq_alumni @WCMQatar Welcome to @mghmedres! Terrific job done!

[Yousef Badran @YRBadran]

@mclean_diaz @AGA_CGH @MGH_GI Congratulations Paige! Beautiful work.

[Yousef Badran @YRBadran]

Great science and insights into MIS-C pathogenesis once again highlighting the importance of collaborative science that @casanova_lab does!

[Casanova Lab @casanova_lab]

1/ Together with the COVID Human Genetics Effort, we are happy to report our finding of inborn errors of the OAS-RNase L pathway in children with MIS-C #Misc #Pims in @ScienceMagazine (https://t.co/91A7lEY3HM)

[Yousef Badran @YRBadran]

@Jbetancourtpr Congratulations Joe, the Fund is so lucky to have you!

[Yousef Badran @YRBadran]

Incredible crew! Welcome to @MGH_GI

[MGH Division of Gastroenterology @MGH_GI]

We are thrilled to announce 📢 our next class of GI fellows, starting in July 2023! We can’t wait to see what you achieve 🌟! Welcome, @MaddieB_MD @kellybuchs @DanielSikavi #PennyNi @brookericemd @MaryamK_Ibrahim 🤩.

@KAnderssonMD
@drraajmehta
@WGoessling

[Yousef Badran @YRBadran]

@mela927 @ldnotar @theNASciences Congratulations @ldnotar!!

[Yousef Badran @YRBadran]

@MGH_GI @mghmedres

[Yousef Badran @YRBadran]

It was an honor working with @drkylestaller and @KlempnerSam on this @NEJM @NEJMCPC highlighting important concepts in GI motility and gastric cancer. Promised good read! https://t.co/Rg7ayPw8yg

[Yousef Badran @YRBadran]

Bevacizumab for persistent Heyde after SAVR/TAVR. It was great working with Zain Virk, @andrewbsong and @HannyAlSamkari on this @MGH_GI

[Andrew Song @andrewbsong]

Zain Virk describes two reports of persistent Heyde syndrome despite SAVR/TAVR. Subsequent bevacizumab controlled their bleeding! More data needed on antiangiogenic therapy for refractory angiodysplastic bleeding. https://t.co/KftkpKqBOL #hematology @HannyAlSamkari @YRBadran 2/2

[Yousef Badran @YRBadran]

A big win for @OUHealth! My good friend @MubeenShakir going back home where I’m sure he will do great things!

[Mubeen Shakir @MubeenShakir]

Very excited to share I’ll be heading home to Oklahoma to join @OUHealth as Associate VP of Clinical Innovation and practice as an internist. Look forward to working with system leaders to continue to improve health care in the state. @OUskullbaseMD @HakeemShakirMD @DaleBratzler

[Yousef Badran @YRBadran]

Thank you to @mghmedres for the roast at the annual Change Show and to @DGlaucomflecken for the shout out! Quite the guest appearance!!